Professional
Added to YB: 2024-01-24
Pitch date: 2024-01-24
ILMN [bullish]
Illumina, Inc.
-3.42%
current return
Author Info
Ensemble Capital creates focused, fundamental-driven portfolios for private & institutional clients. Sign up for the newsletter.
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$18.4B
Pitch Price
$139.64
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.81
P/E
27.05
EV/Sales
4.60
Sector
Life Sciences Tools and Services
Category
growth
Ensemble Capital holding: Illumina ($ILMN)
ILMN 3.56% of fund: New AI algo predicts if genetic mutation causes disease, huge potential for genetic research per NVDA CEO. AI excels at finding patterns in massive datasets, the core of genetic research. PrimateAI-3D trained on genome sequences to ID at-risk patients w low frequency variants
Read full article (1 min)